Table 1.
Group comparison results for other study variables
| Variable | Test (n=12) | Control (n=11) | P |
|---|---|---|---|
| Beta blocker (%) | 7 (58.3) | 10 (90.9) | 0.155 (F) |
| Midazolam | 9.4±3.4 | 12.0±5.1 | 0.143 (W) |
| Etomidate | 4.1±5.2 | 6.8±3.9 | 0.277 (W) |
| Sufentanil | 325.0±406.5 | 730.0±460.8 | 0.056 (W) |
| Grafts | 3.5±0.8 | 3.6±1.3 | 0.842 (W) |
| Infusion T | 248.0±81.0 | 77.3±21.4 | <0.001 (W)* |
| Cross clamp | 87.3±29.4 | 94.0±34.2 | 0.498 (W) |
| CPB | 117.3±31.9 | 129.9±33.1 | 0.479 (W) |
| Crystalloid | 1283.3±327.1 | 1190.9±258.7 | 0.508 (W) |
| Colloids | 791.7±1351.9 | 454.5±187.7 | 0.818 (W) |
| Cell Saver | 2.9±3.6 | 1.5±2.0 | 0.270 (W) |
| Urine output | 637.9±319.2 | 623.2±345.4 | 0.368 (W) |
| Fentanyl | 912.5±1427.4 | 227.3±517.9 | 0.137 (W) |
*Statistically significant, P<0.05. Categorical data are given as frequency (percentage of group). Numeric data are given as mean±SD. F: Fisher exact test, W: Wilcoxon rank sum test, CPB: Cardiopulmonary bypass, SD: Standard deviation